By vgreene, 10 July, 2019 PAM50 (50-gene assay): recommended in conjunction w/ other clinicopathologic variables to guide decisions about adjuvant systemic tx2
By vgreene, 10 July, 2019 MammaPrint (70-gene assay): for pts who ALSO have high clinical risk as defined by MINDACT categorization to inform decisions on withholding adjuvant systemic chemotx2
By vgreene, 10 July, 2019 EndoPredict (12-gene assay): to guide decisions for adjuvant systemic chemotherapy2